Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.
Identifieur interne : 000C30 ( Main/Exploration ); précédent : 000C29; suivant : 000C31Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.
Auteurs : Bryan Hartzler [États-Unis] ; K Michelle Peavy [États-Unis] ; T Ron Jackson [États-Unis] ; Molly Carney [États-Unis]Source :
- Addiction science & clinical practice [ 1940-0640 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- organisation et administration : Thérapie comportementale.
- thérapie : Troubles liés aux opiacés.
- Comportement coopératif, Formation en interne, Humains, Plan de recherche, Sélection de patients, Études rétrospectives.
English descriptors
- KwdEn :
- MESH :
- organization & administration : Behavior Therapy.
- therapy : Opioid-Related Disorders.
- Cooperative Behavior, Humans, Inservice Training, Patient Selection, Research Design, Retrospective Studies.
Abstract
BACKGROUND
Pragmatic trials of empirically-supported behavior therapies may inform clinical and policy decisions concerning therapy sustainment. This retrospective trial design paper describes and discusses pragmatic features of a hybrid type III implementation/effectiveness trial of a contingency management (CM) intervention at an opioid treatment program. Prior reporting (Hartzler et al., J Subst Abuse Treat 46:429-438, 2014; Hartzler, Subst Abuse Treat Prev Policy 10:30, 2015) notes success in recruiting program staff for voluntary participation, durable impacts of CM training on staff-level outcomes, provisional setting implementation of the intervention, documentation of clinical effectiveness, and post-trial sustainment of CM.
METHODS/DESIGN
Six pragmatic design features, and both scientific and practical bases for their inclusion in the trial, are presented: (1) a collaborative intervention design process, (2) voluntary recruitment of program staff for therapy training and implementation, (3) serial training outcome assessments, with quasi-experimental staff randomization to either single or multiple baseline assessment conditions, (4) designation of a 90-day period immediately after training in which the setting implemented the intervention on a provisional basis, (5) inclusive patient eligibility for receipt of the CM intervention, and (6) designation of two staff as local implementation leaders to oversee clinical/administrative issues in provisional implementation.
DISCUSSION
Each pragmatic trial design feature is argued to have contributed to sustainment of CM. Contributions implicate the building of setting proprietorship for the CM intervention, culling of internal staff expertise in its delivery, iterative use of assessment methods that limited setting burden, documentation of setting-specific clinical effectiveness, expanded penetration of CM among staff during provisional implementation, and promotion of setting self-reliance in the oversight of sustainable implementation procedures. It is hoped this discussion offers ideas for how to impact local clinical and policy decisions via effective behavior therapy dissemination.
DOI: 10.1186/s13722-016-0049-6
PubMed: 26801244
PubMed Central: PMC4724112
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.</title><author><name sortKey="Hartzler, Bryan" sort="Hartzler, Bryan" uniqKey="Hartzler B" first="Bryan" last="Hartzler">Bryan Hartzler</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. hartzb@u.washington.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Peavy, K Michelle" sort="Peavy, K Michelle" uniqKey="Peavy K" first="K Michelle" last="Peavy">K Michelle Peavy</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. peavey@evergreentx.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Jackson, T Ron" sort="Jackson, T Ron" uniqKey="Jackson T" first="T Ron" last="Jackson">T Ron Jackson</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. ronjack@u.washington.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Carney, Molly" sort="Carney, Molly" uniqKey="Carney M" first="Molly" last="Carney">Molly Carney</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. mcarney@evergreentx.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26801244</idno><idno type="pmid">26801244</idno><idno type="doi">10.1186/s13722-016-0049-6</idno><idno type="pmc">PMC4724112</idno><idno type="wicri:Area/Main/Corpus">000C40</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C40</idno><idno type="wicri:Area/Main/Curation">000C40</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C40</idno><idno type="wicri:Area/Main/Exploration">000C40</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.</title><author><name sortKey="Hartzler, Bryan" sort="Hartzler, Bryan" uniqKey="Hartzler B" first="Bryan" last="Hartzler">Bryan Hartzler</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. hartzb@u.washington.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Peavy, K Michelle" sort="Peavy, K Michelle" uniqKey="Peavy K" first="K Michelle" last="Peavy">K Michelle Peavy</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. peavey@evergreentx.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Jackson, T Ron" sort="Jackson, T Ron" uniqKey="Jackson T" first="T Ron" last="Jackson">T Ron Jackson</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. ronjack@u.washington.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Carney, Molly" sort="Carney, Molly" uniqKey="Carney M" first="Molly" last="Carney">Molly Carney</name><affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. mcarney@evergreentx.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631</wicri:regionArea><orgName type="university">Université de Washington</orgName><placeName><settlement type="city">Seattle</settlement><region type="state">Washington (État)</region></placeName></affiliation></author></analytic><series><title level="j">Addiction science & clinical practice</title><idno type="eISSN">1940-0640</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behavior Therapy (organization & administration)</term><term>Cooperative Behavior (MeSH)</term><term>Humans (MeSH)</term><term>Inservice Training (MeSH)</term><term>Opioid-Related Disorders (therapy)</term><term>Patient Selection (MeSH)</term><term>Research Design (MeSH)</term><term>Retrospective Studies (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Comportement coopératif (MeSH)</term><term>Formation en interne (MeSH)</term><term>Humains (MeSH)</term><term>Plan de recherche (MeSH)</term><term>Sélection de patients (MeSH)</term><term>Thérapie comportementale (organisation et administration)</term><term>Troubles liés aux opiacés (thérapie)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Thérapie comportementale</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Behavior Therapy</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Opioid-Related Disorders</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Troubles liés aux opiacés</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cooperative Behavior</term><term>Humans</term><term>Inservice Training</term><term>Patient Selection</term><term>Research Design</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Comportement coopératif</term><term>Formation en interne</term><term>Humains</term><term>Plan de recherche</term><term>Sélection de patients</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Pragmatic trials of empirically-supported behavior therapies may inform clinical and policy decisions concerning therapy sustainment. This retrospective trial design paper describes and discusses pragmatic features of a hybrid type III implementation/effectiveness trial of a contingency management (CM) intervention at an opioid treatment program. Prior reporting (Hartzler et al., J Subst Abuse Treat 46:429-438, 2014; Hartzler, Subst Abuse Treat Prev Policy 10:30, 2015) notes success in recruiting program staff for voluntary participation, durable impacts of CM training on staff-level outcomes, provisional setting implementation of the intervention, documentation of clinical effectiveness, and post-trial sustainment of CM.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS/DESIGN</b></p><p>Six pragmatic design features, and both scientific and practical bases for their inclusion in the trial, are presented: (1) a collaborative intervention design process, (2) voluntary recruitment of program staff for therapy training and implementation, (3) serial training outcome assessments, with quasi-experimental staff randomization to either single or multiple baseline assessment conditions, (4) designation of a 90-day period immediately after training in which the setting implemented the intervention on a provisional basis, (5) inclusive patient eligibility for receipt of the CM intervention, and (6) designation of two staff as local implementation leaders to oversee clinical/administrative issues in provisional implementation.</p></div><div type="abstract" xml:lang="en"><p><b>DISCUSSION</b></p><p>Each pragmatic trial design feature is argued to have contributed to sustainment of CM. Contributions implicate the building of setting proprietorship for the CM intervention, culling of internal staff expertise in its delivery, iterative use of assessment methods that limited setting burden, documentation of setting-specific clinical effectiveness, expanded penetration of CM among staff during provisional implementation, and promotion of setting self-reliance in the oversight of sustainable implementation procedures. It is hoped this discussion offers ideas for how to impact local clinical and policy decisions via effective behavior therapy dissemination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26801244</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-0640</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>Addiction science & clinical practice</Title><ISOAbbreviation>Addict Sci Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13722-016-0049-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pragmatic trials of empirically-supported behavior therapies may inform clinical and policy decisions concerning therapy sustainment. This retrospective trial design paper describes and discusses pragmatic features of a hybrid type III implementation/effectiveness trial of a contingency management (CM) intervention at an opioid treatment program. Prior reporting (Hartzler et al., J Subst Abuse Treat 46:429-438, 2014; Hartzler, Subst Abuse Treat Prev Policy 10:30, 2015) notes success in recruiting program staff for voluntary participation, durable impacts of CM training on staff-level outcomes, provisional setting implementation of the intervention, documentation of clinical effectiveness, and post-trial sustainment of CM.</AbstractText><AbstractText Label="METHODS/DESIGN" NlmCategory="METHODS">Six pragmatic design features, and both scientific and practical bases for their inclusion in the trial, are presented: (1) a collaborative intervention design process, (2) voluntary recruitment of program staff for therapy training and implementation, (3) serial training outcome assessments, with quasi-experimental staff randomization to either single or multiple baseline assessment conditions, (4) designation of a 90-day period immediately after training in which the setting implemented the intervention on a provisional basis, (5) inclusive patient eligibility for receipt of the CM intervention, and (6) designation of two staff as local implementation leaders to oversee clinical/administrative issues in provisional implementation.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Each pragmatic trial design feature is argued to have contributed to sustainment of CM. Contributions implicate the building of setting proprietorship for the CM intervention, culling of internal staff expertise in its delivery, iterative use of assessment methods that limited setting burden, documentation of setting-specific clinical effectiveness, expanded penetration of CM among staff during provisional implementation, and promotion of setting self-reliance in the oversight of sustainable implementation procedures. It is hoped this discussion offers ideas for how to impact local clinical and policy decisions via effective behavior therapy dissemination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hartzler</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. hartzb@u.washington.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peavy</LastName><ForeName>K Michelle</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. peavey@evergreentx.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>T Ron</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. ronjack@u.washington.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carney</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, Box 354805, 1107 NE 45th Street, Suite 120, Seattle, WA, 98105-4631, USA. mcarney@evergreentx.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DA025678</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DA025678-01A2</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Addict Sci Clin Pract</MedlineTA><NlmUniqueID>101316917</NlmUniqueID><ISSNLinking>1940-0632</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001521" MajorTopicYN="N">Behavior Therapy</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007318" MajorTopicYN="N">Inservice Training</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009293" MajorTopicYN="N">Opioid-Related Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26801244</ArticleId><ArticleId IdType="doi">10.1186/s13722-016-0049-6</ArticleId><ArticleId IdType="pii">10.1186/s13722-016-0049-6</ArticleId><ArticleId IdType="pmc">PMC4724112</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2004 Oct 30-Nov 5;364(9445):1615-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15519634</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Med Educ Pract. 2011 Mar 07;2:85-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23745079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Behav Anal. 2008 Winter;41(4):517-26</Citation><ArticleIdList><ArticleId IdType="pubmed">19192856</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2013 Aug;45(2):237-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23867032</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Jan;156(1):5-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9892291</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2007 Feb 17;334(7589):349-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Addict. 2010 Nov-Dec;19(6):496-503</Citation><ArticleIdList><ArticleId IdType="pubmed">20958844</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1981 May;2(1):31-49</Citation><ArticleIdList><ArticleId IdType="pubmed">7261638</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2010 Sep;39(2):114-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Addict Sci Clin Pract. 2014;9:6</Citation><ArticleIdList><ArticleId IdType="pubmed">24708748</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2010 Jun 1;109(1-3):167-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20149950</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2006 Nov;101(11):1546-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17034434</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jun 22;342(25):1887-92</Citation><ArticleIdList><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Child Adolesc Psychol. 2014;43(6):915-28</Citation><ArticleIdList><ArticleId IdType="pubmed">24611580</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Sep 24;290(12):1624-32</Citation><ArticleIdList><ArticleId IdType="pubmed">14506122</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2008 Apr;34(3):293-301</Citation><ArticleIdList><ArticleId IdType="pubmed">17600652</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol (New York). 2010 Mar;17(1):1-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20877441</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2014 Sep;109(9):1426-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24750232</ArticleId></ArticleIdList></Reference><Reference><Citation>Subst Abuse Treat Prev Policy. 2015;10:30</Citation><ArticleIdList><ArticleId IdType="pubmed">26243132</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2007 Feb;58(2):181-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17287373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Jan 1-7;365(9453):82-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2003 Aug;93(8):1261-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12893608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2008 Aug;76(4):556-67</Citation><ArticleIdList><ArticleId IdType="pubmed">18665685</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jun 22;342(25):1878-86</Citation><ArticleIdList><ArticleId IdType="pubmed">10861324</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2003 Mar;54(3):333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12610240</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2010 Mar 1;107(2-3):202-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19959299</ArticleId></ArticleIdList></Reference><Reference><Citation>Subst Abus. 2014;35(1):30-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24588290</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2008 Mar 11;5(3):e67</Citation><ArticleIdList><ArticleId IdType="pubmed">18336067</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2006 Feb;101(2):192-203</Citation><ArticleIdList><ArticleId IdType="pubmed">16445548</ArticleId></ArticleIdList></Reference><Reference><Citation>Adm Policy Ment Health. 2011 Jan;38(1):4-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21197565</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2014;349:g6826</Citation><ArticleIdList><ArticleId IdType="pubmed">25446054</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2014 Apr;46(4):429-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24462242</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2001 Aug 15;286(7):821-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11497536</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 1986 Sep;15(5):451-74</Citation><ArticleIdList><ArticleId IdType="pubmed">3534875</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Educ Behav. 2013 Jun;40(3):257-65</Citation><ArticleIdList><ArticleId IdType="pubmed">23709579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2012 Apr;80(2):286-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22250852</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2004 Jan 7;73(1):99-106</Citation><ArticleIdList><ArticleId IdType="pubmed">14687964</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2000 Apr;68(2):250-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10780125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chronic Dis. 1967 Aug;20(8):637-48</Citation><ArticleIdList><ArticleId IdType="pubmed">4860352</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2012 Apr 1;122(1-2):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22153943</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Rev. 2010 Jun;30(4):448-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20304542</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2002 Dec;23(4):309-18</Citation><ArticleIdList><ArticleId IdType="pubmed">12495792</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2015 Aug;55:52-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25770870</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2012 Apr 1;122(1-2):86-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21981991</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Oct;62(10):1148-56</Citation><ArticleIdList><ArticleId IdType="pubmed">16203960</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1993 May;150(5):763-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8480823</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2012 Mar;50(3):217-26</Citation><ArticleIdList><ArticleId IdType="pubmed">22310560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Drug Educ. 2008;38(2):181-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18724657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2005 Feb;73(1):106-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15709837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2014 Jun;82(3):472-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24588405</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1999 Sep;89(9):1322-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10474547</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2007 Sep;33(2):183-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17434708</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2001 Feb;96(2):203-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11182864</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 1998 Apr;66(2):290-303</Citation><ArticleIdList><ArticleId IdType="pubmed">9583332</ArticleId></ArticleIdList></Reference><Reference><Citation>Complement Ther Med. 2004 Jun-Sep;12(2-3):136-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15561524</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2015 Oct;57:41-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26001821</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Crit Care. 2008 Jul;17(4):315-26; quiz 327</Citation><ArticleIdList><ArticleId IdType="pubmed">18593830</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Feb;63(2):201-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16461864</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2013 Aug;45(2):242-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23506780</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2006 Oct 15;85(1):19-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16650657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S44-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20307795</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Drug Policy. 2013 Jul;24(4):333-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22940140</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2006 Oct;31(3):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16996389</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2004 Jun;26(4):305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15182895</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 2005 Jan;28(1):57-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15723733</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Washington (État)</li></region><settlement><li>Seattle</li></settlement><orgName><li>Université de Washington</li></orgName></list><tree><country name="États-Unis"><region name="Washington (État)"><name sortKey="Hartzler, Bryan" sort="Hartzler, Bryan" uniqKey="Hartzler B" first="Bryan" last="Hartzler">Bryan Hartzler</name></region><name sortKey="Carney, Molly" sort="Carney, Molly" uniqKey="Carney M" first="Molly" last="Carney">Molly Carney</name><name sortKey="Jackson, T Ron" sort="Jackson, T Ron" uniqKey="Jackson T" first="T Ron" last="Jackson">T Ron Jackson</name><name sortKey="Peavy, K Michelle" sort="Peavy, K Michelle" uniqKey="Peavy K" first="K Michelle" last="Peavy">K Michelle Peavy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C30 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C30 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26801244
|texte= Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26801244" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |